APA (7th ed.) Citation

B, F., P, N. T. N., L, M., C, L. N., T, V. T., HV, T. K., . . . JN, D. (2023). Rise in alanine aminotransferase after HCV treatment is a highly sensitive screen for treatment failure. Clinical liver disease, 21(5), 138. https://doi.org/10.1097/CLD.0000000000000055

Chicago Style (17th ed.) Citation

B, Flower, et al. "Rise in Alanine Aminotransferase After HCV Treatment Is a Highly Sensitive Screen for Treatment Failure." Clinical Liver Disease 21, no. 5 (2023): 138. https://doi.org/10.1097/CLD.0000000000000055.

MLA (9th ed.) Citation

B, Flower, et al. "Rise in Alanine Aminotransferase After HCV Treatment Is a Highly Sensitive Screen for Treatment Failure." Clinical Liver Disease, vol. 21, no. 5, 2023, p. 138, https://doi.org/10.1097/CLD.0000000000000055.